138 related articles for article (PubMed ID: 10464528)
1. [Caffeine skinned fiber tension test: application to the diagnosis of susceptibility to malignant hyperthermia].
Adnet P; Börtlein ML; Tavernier B; Nivoche Y; Etchrivi T; Krivosic-Horber R; Haudecoeur G
Ann Fr Anesth Reanim; 1999 Jun; 18(6):624-30. PubMed ID: 10464528
[TBL] [Abstract][Full Text] [Related]
2. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
[TBL] [Abstract][Full Text] [Related]
3. Fiber-type caffeine sensitivities in skinned muscle fibers from humans susceptible to malignant hyperthermia.
Adnet PJ; Bromberg NL; Haudecoeur G; Krivosic I; Adamantidis MM; Reyford H; Bello N; Krivosic Horber RM
Anesthesiology; 1993 Jan; 78(1):168-77. PubMed ID: 8424551
[TBL] [Abstract][Full Text] [Related]
4. Sources of variability in halothane and caffeine contracture tests for susceptibility to malignant hyperthermia.
Ording H; Bendixen D
Eur J Anaesthesiol; 1992 Sep; 9(5):367-76. PubMed ID: 1396623
[TBL] [Abstract][Full Text] [Related]
5. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the caffeine skinned fibre tension (CSFT) test with the caffeine-halothane contracture (CHC) test in the diagnosis of malignant hyperthermia.
Britt BA; Frodis W; Scott E; Clements MJ; Endrenyi L
Can Anaesth Soc J; 1982 Nov; 29(6):550-62. PubMed ID: 7139394
[TBL] [Abstract][Full Text] [Related]
7. Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility.
Wappler F; Anetseder M; Baur CP; Censier K; Doetsch S; Felleiter P; Fiege M; Fricker R; Halsall PJ; Hartung E; Heffron JJ; Heytens L; Hopkins PM; Klingler W; Lehmann-Horn F; Nivoche Y; Tegazzin V; Tzanova I; Urwyler A; Weisshorn R; Schulte am Esch J
Eur J Anaesthesiol; 2003 Jul; 20(7):528-36. PubMed ID: 12884985
[TBL] [Abstract][Full Text] [Related]
8. Malignant hyperthermia (MH) diagnostics: a comparison between the halothane-caffeine- and the ryanodine-contracture-test results in MH susceptible, normal and control muscle.
Hartung E; Koob M; Anetseder M; Schoemig P; Krauspe R; Hogrefe G; Engelhardt W
Acta Anaesthesiol Scand; 1996 Apr; 40(4):437-44. PubMed ID: 8738688
[TBL] [Abstract][Full Text] [Related]
9. An analysis of the predictive probability of the in vitro contracture test for determining susceptibility to malignant hyperthermia.
Hopkins PM; Ellis FR; Halsall PJ; Stewart AD
Anesth Analg; 1997 Mar; 84(3):648-56. PubMed ID: 9052318
[TBL] [Abstract][Full Text] [Related]
10. Mg2+ dependence of halothane-induced Ca2+ release from the sarcoplasmic reticulum in skeletal muscle from humans susceptible to malignant hyperthermia.
Duke AM; Hopkins PM; Halsal JP; Steele DS
Anesthesiology; 2004 Dec; 101(6):1339-46. PubMed ID: 15564941
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
López JR; Contreras J; Linares N; Allen PD
Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
[TBL] [Abstract][Full Text] [Related]
14. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia.
Duke AM; Hopkins PM; Halsall PJ; Steele DS
Br J Anaesth; 2006 Sep; 97(3):320-8. PubMed ID: 16849381
[TBL] [Abstract][Full Text] [Related]
15. Caffeine- or halothane-induced contractures of masseter muscle are similar to those of vastus muscle in normal humans.
Melton AT; Antognini JF; Gronert GA
Acta Anaesthesiol Scand; 1999 Aug; 43(7):764-9. PubMed ID: 10456818
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.
Serfas KD; Bose D; Patel L; Wrogemann K; Phillips MS; MacLennan DH; Greenberg CR
Anesthesiology; 1996 Feb; 84(2):322-9. PubMed ID: 8602662
[TBL] [Abstract][Full Text] [Related]
17. Fiber-type specific caffeine sensitivities in normal human skinned muscle fibers.
Mitsumoto H; DeBoer GE; Bunge G; Andrish JT; Tetzlaff JE; Cruse RP
Anesthesiology; 1990 Jan; 72(1):50-4. PubMed ID: 2136977
[TBL] [Abstract][Full Text] [Related]
18. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
[TBL] [Abstract][Full Text] [Related]
19. Negative inotropic effect of heparin on tension development in rat skinned skeletal muscle fibres.
Talon S; Huchet-Cadiou C; Léoty C
Eur J Pharmacol; 1997 May; 327(1):33-40. PubMed ID: 9185833
[TBL] [Abstract][Full Text] [Related]
20. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
Sato N; Brum JM; Mitsumoto H; DeBoer GE
Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
